TrialHIV medicine2025

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies.

C Martorell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.